Global /India /Healthcare /Drug Manufacturers - General /SOTAC
chevron_leftBack
Sotac Pharmaceuticals Ltd. logo

Sotac Pharmaceuticals Ltd.

SOTAC
NSE: SOTAC Delayed
117.00INR 4.5%
1.24 USD
As of 20 June 2026, Sotac Pharmaceuticals Ltd. has a market cap of $13.7M USD, ranking #39543 globally and #2998 in India. It ranks #3530 in the Healthcare sector, and #1153 in the Drug Manufacturers - General industry.
Global Rank
39543
Country Rank
2998
Sector Rank
3530
Industry Rank
1153
Key Stats
Market Cap
$13.7MUSD
1.29B INR
Enterprise Value
$18.07MUSD
1.71B INR
Revenue (TTM)
$8.97MUSD
846.72M INR
EBITDA (TTM)
$1.72MUSD
162.79M INR
Net Income (TTM)
$906.92KUSD
85.6M INR
EBITDA Margin
19%
Profit Margin
10%
PE Ratio
15.1
PS Ratio
1.5
PB Ratio
2.1
EV/EBITDA
10.5
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Sharadkumar Patel open_in_new
Employees
127
Founded
2014
Website
sotacpharma.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
4.5% 16% 5.8% 17% -6.4% -1.4%

News

Loading...

Markets

Exchange Ticker Price
National Stock Exchange of India
MIC: XNSE
PRIMARY
SOTAC
Sotac Pharmaceuticals Ltd Ordinary Shares
ISIN: INE0O2D01012
Shares Out.:
11.05M1
TV:
SA:
YF:
GF:
BA:
MS:
117.00 INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Sotac Pharmaceuticals Ltd.

Sotac Pharmaceuticals Limited engages in the production, manufacturing, processing, and sale of various pharmaceutical products in India. Its therapeutic product portfolio includes anti-diabetic, anti-psychotic, vitamins, minerals, iron supplements, anti-cold, anti-allergic, dermatological solutions, antacid, anti-ulcerants, PPI, anti-emetics, cardiac, anti-hypertensives, analgesic, anti-pyretic, anti-inflammatory, anti-bacterial, anti-viral, general antibiotics, IP-lactams and non-IP-lactams, anti-fungal, and cephalosporin products. The company also offers non-beta lactam general tablets, beta lactam coated tablets, beta lactam uncoated tablets, non-beta lactam general capsules, beta‐lactam capsules, oral liquid, dry syrup and external preparations such as nasal spray, relief spray and creams. In addition, it is involved in the research of pharmaceutical molecules used in developing new pharmaceutical formulations; and manufacture of nutraceuticals and food products. The company also exports its products. Sotac Pharmaceuticals Limited was founded in 2014 and is based in Ahmedabad, India.

Similar Companies

Industry: Drug Manufacturers - General (India)
Name
Market Cap diff.
PE
$45.22B
4.27T INR
330K%
39.1
DIVISLAB
$18.38B
1.73T INR
134K%
70.0
$15.17B
1.43T INR
111K%
63.0
$11.73B
1.11T INR
86K%
19.6
MANKIND
$9.87B
931.67B INR
72K%
52.2
ZYDUSLIFE
$9.71B
916.53B INR
71K%
18.6
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
6M%
38.1
JNJ
$547.28B
4M%
26.4
ABBV
$360.63B
3M%
97.4
$318.3B
256.25B CHF
2M%
19.9
AZN
$284.64B
215.59B GBP
2M%
27.6
MRK
$274.03B
2M%
15.1
chevron_leftBack